new BindingDB logo
myBDB logout

BDBM285546 3-(4-cyano-5-fluoro-2-methylphenyl)-N-cyclo-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 19::US9598421, Example 19

SMILES: Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)NC1CC1

InChI Key:

Data: 8 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 285546   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3


(Homo sapiens (Human))
BDBM285546
PNG
(3-(4-cyano-5-fluoro-2-methylphenyl)-N-cyclo-propyl...)
Show SMILES Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)NC1CC1 |(2.81,-8.2,;4.3,-7.8,;4.7,-6.31,;6.18,-5.91,;6.58,-4.42,;6.9,-2.92,;7.27,-7,;8.76,-6.6,;6.88,-8.49,;5.39,-8.89,;4.99,-10.37,;5.89,-11.62,;4.99,-12.87,;3.52,-12.39,;2.19,-13.16,;.86,-12.39,;.86,-10.85,;2.19,-10.08,;3.52,-10.85,;7.43,-11.62,;8.2,-10.29,;8.2,-12.95,;9.74,-12.95,;11.08,-13.72,;11.08,-12.18,)|
PDB

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
US Patent
n/an/a 16.9n/an/an/an/an/an/a



Pfizer Inc.

US Patent




US Patent US10077269 (2018)


Article DOI: 10.1021/jm0204183
BindingDB Entry DOI: 10.7270/Q2P84DX5
More data for this
Ligand-Target Pair
cAMP-specific 3',5'-cyclic phosphodiesterase 4B


(Homo sapiens (Human))
BDBM285546
PNG
(3-(4-cyano-5-fluoro-2-methylphenyl)-N-cyclo-propyl...)
Show SMILES Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)NC1CC1 |(2.81,-8.2,;4.3,-7.8,;4.7,-6.31,;6.18,-5.91,;6.58,-4.42,;6.9,-2.92,;7.27,-7,;8.76,-6.6,;6.88,-8.49,;5.39,-8.89,;4.99,-10.37,;5.89,-11.62,;4.99,-12.87,;3.52,-12.39,;2.19,-13.16,;.86,-12.39,;.86,-10.85,;2.19,-10.08,;3.52,-10.85,;7.43,-11.62,;8.2,-10.29,;8.2,-12.95,;9.74,-12.95,;11.08,-13.72,;11.08,-12.18,)|
PDB

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
US Patent
n/an/a 13.6n/an/an/an/an/an/a



Pfizer Inc.

US Patent




US Patent US10077269 (2018)


Article DOI: 10.1021/jm0204183
BindingDB Entry DOI: 10.7270/Q2P84DX5
More data for this
Ligand-Target Pair
cAMP-specific 3',5'-cyclic phosphodiesterase 4C isoform 1


(Homo sapiens (Human))
BDBM285546
PNG
(3-(4-cyano-5-fluoro-2-methylphenyl)-N-cyclo-propyl...)
Show SMILES Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)NC1CC1 |(2.81,-8.2,;4.3,-7.8,;4.7,-6.31,;6.18,-5.91,;6.58,-4.42,;6.9,-2.92,;7.27,-7,;8.76,-6.6,;6.88,-8.49,;5.39,-8.89,;4.99,-10.37,;5.89,-11.62,;4.99,-12.87,;3.52,-12.39,;2.19,-13.16,;.86,-12.39,;.86,-10.85,;2.19,-10.08,;3.52,-10.85,;7.43,-11.62,;8.2,-10.29,;8.2,-12.95,;9.74,-12.95,;11.08,-13.72,;11.08,-12.18,)|
PDB

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
US Patent
n/an/a 98.4n/an/an/an/an/an/a



Pfizer Inc.

US Patent




US Patent US10077269 (2018)


Article DOI: 10.1021/jm0204183
BindingDB Entry DOI: 10.7270/Q2P84DX5
More data for this
Ligand-Target Pair
Phosphodiesterase 4D


(Homo sapiens (Human))
BDBM285546
PNG
(3-(4-cyano-5-fluoro-2-methylphenyl)-N-cyclo-propyl...)
Show SMILES Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)NC1CC1 |(2.81,-8.2,;4.3,-7.8,;4.7,-6.31,;6.18,-5.91,;6.58,-4.42,;6.9,-2.92,;7.27,-7,;8.76,-6.6,;6.88,-8.49,;5.39,-8.89,;4.99,-10.37,;5.89,-11.62,;4.99,-12.87,;3.52,-12.39,;2.19,-13.16,;.86,-12.39,;.86,-10.85,;2.19,-10.08,;3.52,-10.85,;7.43,-11.62,;8.2,-10.29,;8.2,-12.95,;9.74,-12.95,;11.08,-13.72,;11.08,-12.18,)|
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
US Patent
n/an/a 645n/an/an/an/an/an/a



Pfizer Inc.

US Patent




US Patent US9598421 (2017)


Article DOI: 10.1021/jm030933g
BindingDB Entry DOI: 10.7270/Q2K939KG
More data for this
Ligand-Target Pair
Phosphodiesterase 4A (PDE4)


(Homo sapiens (Human))
BDBM285546
PNG
(3-(4-cyano-5-fluoro-2-methylphenyl)-N-cyclo-propyl...)
Show SMILES Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)NC1CC1 |(2.81,-8.2,;4.3,-7.8,;4.7,-6.31,;6.18,-5.91,;6.58,-4.42,;6.9,-2.92,;7.27,-7,;8.76,-6.6,;6.88,-8.49,;5.39,-8.89,;4.99,-10.37,;5.89,-11.62,;4.99,-12.87,;3.52,-12.39,;2.19,-13.16,;.86,-12.39,;.86,-10.85,;2.19,-10.08,;3.52,-10.85,;7.43,-11.62,;8.2,-10.29,;8.2,-12.95,;9.74,-12.95,;11.08,-13.72,;11.08,-12.18,)|
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
US Patent
n/an/a 16.9n/an/an/an/an/an/a



Pfizer Inc.

US Patent




US Patent US9598421 (2017)


Article DOI: 10.1021/jm030933g
BindingDB Entry DOI: 10.7270/Q2K939KG
More data for this
Ligand-Target Pair
Phosphodiesterase 4B (PDE4B)


(Homo sapiens (Human))
BDBM285546
PNG
(3-(4-cyano-5-fluoro-2-methylphenyl)-N-cyclo-propyl...)
Show SMILES Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)NC1CC1 |(2.81,-8.2,;4.3,-7.8,;4.7,-6.31,;6.18,-5.91,;6.58,-4.42,;6.9,-2.92,;7.27,-7,;8.76,-6.6,;6.88,-8.49,;5.39,-8.89,;4.99,-10.37,;5.89,-11.62,;4.99,-12.87,;3.52,-12.39,;2.19,-13.16,;.86,-12.39,;.86,-10.85,;2.19,-10.08,;3.52,-10.85,;7.43,-11.62,;8.2,-10.29,;8.2,-12.95,;9.74,-12.95,;11.08,-13.72,;11.08,-12.18,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
US Patent
n/an/a 13.6n/an/an/an/an/an/a



Pfizer Inc.

US Patent




US Patent US9598421 (2017)


Article DOI: 10.1021/jm030933g
BindingDB Entry DOI: 10.7270/Q2K939KG
More data for this
Ligand-Target Pair
Phosphodiesterase 4C


(Homo sapiens (Human))
BDBM285546
PNG
(3-(4-cyano-5-fluoro-2-methylphenyl)-N-cyclo-propyl...)
Show SMILES Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)NC1CC1 |(2.81,-8.2,;4.3,-7.8,;4.7,-6.31,;6.18,-5.91,;6.58,-4.42,;6.9,-2.92,;7.27,-7,;8.76,-6.6,;6.88,-8.49,;5.39,-8.89,;4.99,-10.37,;5.89,-11.62,;4.99,-12.87,;3.52,-12.39,;2.19,-13.16,;.86,-12.39,;.86,-10.85,;2.19,-10.08,;3.52,-10.85,;7.43,-11.62,;8.2,-10.29,;8.2,-12.95,;9.74,-12.95,;11.08,-13.72,;11.08,-12.18,)|
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
US Patent
n/an/a 98.4n/an/an/an/an/an/a



Pfizer Inc.

US Patent




US Patent US9598421 (2017)


Article DOI: 10.1021/jm030933g
BindingDB Entry DOI: 10.7270/Q2K939KG
More data for this
Ligand-Target Pair
cAMP-specific 3',5'-cyclic phosphodiesterase 4D


(Homo sapiens (Human))
BDBM285546
PNG
(3-(4-cyano-5-fluoro-2-methylphenyl)-N-cyclo-propyl...)
Show SMILES Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)NC1CC1 |(2.81,-8.2,;4.3,-7.8,;4.7,-6.31,;6.18,-5.91,;6.58,-4.42,;6.9,-2.92,;7.27,-7,;8.76,-6.6,;6.88,-8.49,;5.39,-8.89,;4.99,-10.37,;5.89,-11.62,;4.99,-12.87,;3.52,-12.39,;2.19,-13.16,;.86,-12.39,;.86,-10.85,;2.19,-10.08,;3.52,-10.85,;7.43,-11.62,;8.2,-10.29,;8.2,-12.95,;9.74,-12.95,;11.08,-13.72,;11.08,-12.18,)|
PDB

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
US Patent
n/an/a 645n/an/an/an/an/an/a



Pfizer Inc.

US Patent




US Patent US10077269 (2018)


Article DOI: 10.1021/jm0204183
BindingDB Entry DOI: 10.7270/Q2P84DX5
More data for this
Ligand-Target Pair